Evidence map›Paper›PMID 34306159›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Pharmacokinetics and Tissue Distribution of Combined Triptolide and Paeoniflorin Regimen for Percutaneous Administration in Rats Assessed by Liquid Chromatography-Tandem Mass Spectrometry.

Yong-Mei Guan, Qian Shen, Liang-Fei He, Li-Mei Chen, Zhenzhong Zang, Lili Liu, Wei-Feng Zhu, Chen Li-Hua, Hong-Ning Liu

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yong-Mei GuanJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0001-8673-4264
Qian ShenJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0001-9210-2087
Liang-Fei HeJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0003-3884-3559
Li-Mei ChenJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0002-2029-5606
Zhenzhong ZangJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0002-6648-3514
Lili LiuJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0001-8212-7360
Wei-Feng ZhuJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0002-5661-5472
Chen Li-HuaJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0002-6313-6496
Hong-Ning LiuJiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.ORCID https://orcid.org/0000-0002-8246-4073
Jiangxi University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triptolide (TP) has shown potential in rheumatoid arthritis (RA) treatment, but the narrow therapeutic window limits its clinical application. In clinical practice, the compatibility of

Identifiers

PMID34306159
PMCPMC8282371
OpenAlexW3178464239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.